Cart
sales@molnova.com
Darifenacin HBr
CAS No. 133099-07-7
Darifenacin HBr( UK 88525-04 )
Catalog No. M11319 CAS No. 133099-07-7
Darifenacin is a selective muscarinic receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 38 | In Stock |
|
| 100MG | 45 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDarifenacin HBr
-
NoteResearch use only, not for human use.
-
Brief DescriptionDarifenacin is a selective muscarinic receptor antagonist.
-
DescriptionDarifenacin is a selective muscarinic receptor antagonist.
-
In Vitro——
-
In Vivo——
-
SynonymsUK 88525-04
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptorM3 mAChR
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number133099-07-7
-
Formula Weight505.45
-
Molecular FormulaC28H31BrN2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 117 mg/mL (230.56 mM)
-
SMILESC1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5.Br
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Moriya H, et al. Life Sci. 1999; 64(25):2351-8.
molnova catalog
related products
-
α-Conotoxin AuIB
Selective antagonist of α3β4 nicotinic acetylcholine receptors. Displays > 100-fold selectivity over other receptor subunit combinations including α2β2, α2β4, α3β2, α4β2, α4β4 and α1β1γδ.
-
PHA 568487
The quinuclidine PHA 568487 is an agonist of the alpha 7 nicotinic acetylcholine receptor that was designed to mitigate the bioactivation associated with the core scaffold and subsequently remove associated liabilities with in vivo tolerability.
-
Mecamylamine hydroch...
A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier.
